Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Treatment outcome of first episode schizophrenia.

Lieberman J, Jody D, Geisler S, Vital-Herne J, Alvir JM, Walsleben J, Woerner MG.

Psychopharmacol Bull. 1989;25(1):92-6. No abstract available.

PMID:
2772122
2.

Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.

Kopala LC, Fredrikson D, Good KP, Honer WG.

Biol Psychiatry. 1996 Feb 15;39(4):296-8. No abstract available.

PMID:
8645777
3.

Obstetric complications predict treatment response in first-episode schizophrenia.

Alvir JM, Woerner MG, Gunduz H, Degreef G, Lieberman JA.

Psychol Med. 1999 May;29(3):621-7.

PMID:
10405083
4.

Early use of clozapine for poorly responding first-episode psychosis.

Agid O, Remington G, Kapur S, Arenovich T, Zipursky RB.

J Clin Psychopharmacol. 2007 Aug;27(4):369-73.

PMID:
17632221
5.

Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia.

Uçok A, Polat A, Genç A, Cakir S, Turan N.

J Psychiatr Res. 2004 Mar-Apr;38(2):163-8.

PMID:
14757330
6.

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.

Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.

Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):129-40.

PMID:
15146342
7.

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC, Woerner MG, Schooler NR, Kane JM, Robinson DG.

Arch Gen Psychiatry. 2007 Oct;64(10):1115-22.

PMID:
17909123
8.

The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.

Hofer A, Hummer M, Kemmler G, Kurz M, Kurzthaler I, Fleischhacker WW.

Int J Neuropsychopharmacol. 2003 Sep;6(3):201-6.

PMID:
12974985
9.

Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.

J Clin Psychiatry. 1999 Nov;60(11):747-51.

PMID:
10584762
10.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
11.

Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.

Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G; HGDH Research Group.

Br J Psychiatry. 2004 Jul;185:18-24.

12.

Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial.

Takahashi H, Yoshida K, Ishigooka J, Higuchi H.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1067-72. Epub 2006 Jun 8.

PMID:
16759777
13.

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

Takahashi H, Kamata M, Yoshida K, Ishigooka J, Higuchi H.

J Clin Psychiatry. 2006 Oct;67(10):1577-82.

PMID:
17107250
14.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
15.
16.

Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.

de Haan L, van Amelsvoort T, Dingemans P, Linszen D.

Pharmacopsychiatry. 2007 Nov;40(6):264-8.

PMID:
18030650
17.

Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis.

Melle I, Larsen TK, Haahr U, Friis S, Johannesen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T.

Arch Gen Psychiatry. 2008 Jun;65(6):634-40. doi: 10.1001/archpsyc.65.6.634.

PMID:
18519821
18.

Antipsychotic drug effects on brain morphology in first-episode psychosis.

Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group.

Arch Gen Psychiatry. 2005 Apr;62(4):361-70.

PMID:
15809403
19.

Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.

Novak B, Milcinski M, Grmek M, Kocmur M.

Neuro Endocrinol Lett. 2005 Dec;26(6):685-9.

PMID:
16380684
20.

Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: a replication.

Tandon R, Ribeiro SC, DeQuardo JR, Goldman RS, Goodson J, Greden JF.

Biol Psychiatry. 1993 Oct 1;34(7):495-7. No abstract available.

PMID:
7903556
Items per page

Supplemental Content

Write to the Help Desk